| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,321 |
23,810 |
$2.41M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,762 |
22,020 |
$1.49M |
| 99199 |
Unlisted special service, procedure or report |
254,206 |
154,629 |
$1.47M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19,349 |
16,279 |
$803K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,030 |
5,512 |
$589K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,427 |
3,472 |
$505K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,304 |
3,583 |
$349K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,720 |
3,243 |
$323K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15,352 |
12,156 |
$119K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,090 |
919 |
$100K |
| 87631 |
|
1,200 |
828 |
$79K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,570 |
4,324 |
$63K |
| 96127 |
|
16,015 |
12,899 |
$58K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,861 |
1,719 |
$50K |
| 99401 |
|
1,592 |
1,137 |
$42K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,941 |
1,813 |
$36K |
| 96161 |
|
11,507 |
8,304 |
$32K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
403 |
362 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,832 |
859 |
$23K |
| 92551 |
|
15,284 |
12,970 |
$19K |
| 99050 |
|
756 |
647 |
$17K |
| 87070 |
|
1,842 |
1,579 |
$16K |
| D0145 |
Oral evaluation for a patient under three years of age |
472 |
433 |
$14K |
| 90686 |
|
7,384 |
6,088 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
217 |
147 |
$9K |
| 99173 |
|
10,496 |
8,963 |
$8K |
| 99383 |
|
59 |
53 |
$7K |
| D1206 |
Topical application of fluoride varnish |
472 |
433 |
$6K |
| 99051 |
|
231 |
215 |
$5K |
| 99070 |
|
1,030 |
771 |
$5K |
| 85018 |
|
2,322 |
1,950 |
$5K |
| 90670 |
|
1,446 |
1,136 |
$2K |
| 83655 |
|
171 |
127 |
$2K |
| 90480 |
|
41 |
40 |
$2K |
| 99382 |
|
17 |
13 |
$2K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$2K |
| 90651 |
|
218 |
178 |
$2K |
| 90723 |
|
1,275 |
1,100 |
$2K |
| 88738 |
|
212 |
191 |
$1K |
| 90680 |
|
920 |
782 |
$1K |
| 90734 |
|
45 |
39 |
$1K |
| 90473 |
|
27 |
27 |
$579.69 |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
13 |
13 |
$510.02 |
| 90671 |
|
1,114 |
1,063 |
$456.90 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
12 |
$445.30 |
| 90647 |
|
1,041 |
909 |
$341.64 |
| 90461 |
|
105 |
53 |
$138.60 |
| 90672 |
|
33 |
33 |
$99.28 |
| 81002 |
|
17 |
12 |
$28.35 |
| 94760 |
|
13 |
12 |
$10.35 |
| 36416 |
|
797 |
741 |
$3.16 |
| 99174 |
|
1,338 |
1,064 |
$0.00 |
| 90656 |
|
716 |
698 |
$0.00 |
| 90716 |
|
104 |
95 |
$0.00 |
| 90619 |
|
77 |
65 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 90633 |
|
236 |
191 |
$0.00 |
| 90685 |
|
225 |
221 |
$0.00 |
| 90707 |
|
103 |
94 |
$0.00 |
| 90700 |
|
42 |
40 |
$0.00 |
| 90713 |
|
13 |
13 |
$0.00 |
| 90715 |
|
34 |
26 |
$0.00 |